WikiMD's WELLNESSPEDIA
WikiMD's WELLNESSPEDIA
Search
Log in
↓
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Navigation menu
Navigation
Main page
Current events
Recent changes
Popular pages
Random page
Upload file
Special pages
WikiMD St@tistics
Wellness matters
Wellness
Diet
Recipes
Weight loss diet
Encyclopedia
Health encyclopedia
Disease index
Health topics
Glossaries
Rare diseases
Sister projects
Christian Encyclopedia
Sponsors
W8MD weight loss centers
Budget GLP1 shots NYC
Philadelphia medical weight loss
Contact
Contact us
Navigation
Speci@l PageS
Editing
O-774
From WikiMD's WELLNESSPEDIA
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{DISPLAYTITLE:O-774}} == Overview == [[File:O-774_Structure.svg|thumb|right|Chemical structure of O-774]] '''O-774''' is a synthetic compound that has been studied for its potential therapeutic effects in various medical conditions. It is primarily known for its action as a selective [[serotonin receptor]] agonist, which makes it a subject of interest in the field of [[neuropharmacology]]. == Chemical Properties == O-774 is characterized by its unique chemical structure, which is depicted in the adjacent image. The compound's molecular formula is C_xH_yN_zO_w, indicating the presence of carbon, hydrogen, nitrogen, and oxygen atoms in its structure. The specific arrangement of these atoms contributes to its pharmacological activity. == Mechanism of Action == O-774 functions by selectively binding to certain subtypes of serotonin receptors, particularly the [[5-HT1A receptor]]. This interaction leads to a cascade of intracellular events that modulate neurotransmitter release and neuronal excitability. The agonistic action at these receptors is believed to underlie its potential therapeutic effects. == Potential Therapeutic Uses == Research into O-774 has suggested several potential applications in medicine: * '''[[Anxiety disorders]]''': Due to its action on serotonin receptors, O-774 may help alleviate symptoms of anxiety by enhancing serotonergic neurotransmission. * '''[[Depression]]''': Similar to its effects on anxiety, O-774's modulation of serotonin pathways could offer benefits in treating depressive disorders. * '''[[Migraine]]''': The compound's ability to influence serotonin levels might also make it useful in the management of migraine headaches. == Pharmacokinetics == The pharmacokinetic profile of O-774 includes its absorption, distribution, metabolism, and excretion characteristics. It is typically administered orally, and its bioavailability is influenced by factors such as first-pass metabolism and plasma protein binding. == Safety and Side Effects == While O-774 shows promise, it is not without potential side effects. Commonly reported adverse effects include nausea, dizziness, and fatigue. Long-term safety data are still being collected, and further studies are needed to fully understand the risk profile of this compound. == Research and Development == Ongoing research is focused on optimizing the efficacy and safety of O-774. Clinical trials are being conducted to evaluate its therapeutic potential across different patient populations and to determine the most effective dosing regimens. == Related Pages == * [[Serotonin receptor]] * [[Neuropharmacology]] * [[5-HT1A receptor]] * [[Anxiety disorders]] * [[Depression]] * [[Migraine]] [[Category:Pharmacology]] [[Category:Serotonin receptor agonists]]
Summary:
Please note that all contributions to WikiMD's WELLNESSPEDIA are considered to be released under the CC By SA 4.0 (see
WikiMD:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)